Showing 9 posts of 9 posts found.


Wockhardt launches $40m manufacturing plant in Dubai

July 30, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma

Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …


Wockhardt’s Gujarat plant hit with FDA warning letter

January 5, 2017
Manufacturing and Production FDA, Wockhardt

Indian pharma and biotech firm Wockhardt has been accused of violating current good manufacturing practice (CGMP) regulations in a letter …


Wockhardt UK sterile site hit with FDA warning

November 29, 2016
Manufacturing and Production FDA, Wockhardt, Wrexham

Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter …

FDA slaps import ban on Wockhardt facility

November 29, 2013
Manufacturing and Production FDA, MHRA, Wockhardt, recall

The US Food and Drug Administration has banned imports of medicines made at Wockhardt’s Chikalthana plant in India that failed …

wockhardt image

MHRA recalls five Wockhardt medicines

October 18, 2013
Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall

The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …

Manufacturing image

Manufacturing and production news in brief

September 6, 2013
Manufacturing and Production GSK, Jabones Pardo, Mylan, Shasun, Wockhardt

A round-up of pharma manufacturing facility news, with updates from Wockhardt, Mylan, GSK and Shasun, plus an FDA warning letter …

wockhardt image

FDA warning letter for troubled Wockhardt plant

July 23, 2013
Manufacturing and Production FDA, Wockhardt, warning

The US regulator has issued a warning letter to a facility operated by Indian drugmaker Wockhardt already subject to an …

wockhardt image

MHRA orders recall of Wockhardt drugs after import ban

July 11, 2013
Manufacturing and Production MHRA, Wockhardt, recall

The UK regulatory authority has asked for a recall of medicines made at a Wockhardt facility in India, shortly after …

CP Pharma gets FDA warning for Wrexham facility

November 18, 2010
Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing

UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …

Latest content